Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

• Status: RECRUITING
• Trial end date: 2026-12-31

Summary

In this study, we propose to use the combination of ET-SPACE NIR irradiation whole-body thermal stimulation, ICI (Tislelizumab), and RTK inhibitor (Anlotinib) in the multimodal treatment of CRPC.

• Phase: PHASE2

Details

• Lead Sponsor: Pengyuan Liu
• Treatments: anlotinib; Diathermy; Immune Checkpoint Inhibitors; Immunotherapy; tislelizumab